RBOT (Vicarious Surgical Inc.) Stock Analysis - Analyst Ratings

Vicarious Surgical Inc. (RBOT) is a publicly traded Healthcare sector company. As of May 21, 2026, RBOT trades at $1.92 with a market cap of $13.67M and a P/E ratio of 0.00. RBOT moved -3.52% today. Year to date, RBOT is -80.05%; over the trailing twelve months it is -96.02%. Its 52-week range spans $0.27 to $19.00. Analyst consensus is hold with an average price target of $8.75. Rallies surfaces RBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate RBOT?

5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is hold. The average price target is $8.75.

RBOT Key Metrics

Key financial metrics for RBOT
MetricValue
Price$1.92
Market Cap$13.67M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$19.00
52-Week Low$0.27
Volume53.79K
Avg Volume0
Revenue (TTM)$0
Net Income$-63.22M
Gross Margin0.00%

RBOT Analyst Consensus

5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $8.75.

Latest RBOT News

Recent RBOT Insider Trades

  • Sachs Adam David sold 942 (~$1.97K) on Feb 20, 2026.
  • Khalifa Sammy sold 754 (~$1.57K) on Feb 20, 2026.
  • Sachs Adam David sold 463 (~$1.37K) on Dec 3, 2025.

Common questions about RBOT

What do analysts rate RBOT?
5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is hold. The average price target is $8.75.
Does Rallies show RBOT price targets?
Yes. Rallies tracks RBOT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is RBOT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RBOT. It does not provide personalized investment advice.
RBOT

RBOT